Anna C. Pavlick, DO, MBA, joined Weill Cornell Medicine Meyer Cancer Center in August 2020 as a Professor of Medicine in the Division of Medical Oncology and as
the Founding Director of the Melanoma and Cutaneous Malignancy Program. She is also the Associate Director for Clinical Research and Medical Director of the Weill Cornell Medicine-Meyer Cancer Center Clinical Trials Office. She serves on the Clinical Research Leadership Committee and is the Chairman of the Feasibility Review Committee.
Her research focuses upon novel immunologic and targeted therapies for melanoma and rare cutaneous malignancies. She has published on both clinical and translational aspects of melanoma research. Dr. Pavlick has developed an extensive translational, clinical trials program in melanoma which correlates tumor response with biomarkers from serum and tumors. She is also collaborating in the development of the solid tumor cellular therapy service at Cornell.
She serves on several editorial boards and melanoma advisory boards. She has published extensively in peer-reviewed journals and has been an invited speaker
at national and international conferences. As an active melanoma awareness educator, Dr. Pavlick participates in numerous outreach community activities.